Back

When to consider left atrial appendage occlusion

28 August 2026 (11:00 - 11:15)
Organised by: Logo
Congress Presentation Part of: Challenges with antithrombotic strategies in atrial fibrillation and coronary disease: time to personalise? Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)

3 More presentations in this session

Presentation thumbnail
Personalised antithrombotic therapy after atrial fibrillation ablation
Professor R. Schnabel (Hamburg, DE)
Slides Video
Presentation thumbnail
Can we stop anticoagulation after successful atrial fibrillation ablation?
Doctor V. Markides (London, GB)
Slides Video
Presentation thumbnail
Novel antithrombotic strategies in atrial fibrillation: time to personalise? - patient perspective
Mr M. Madigan (Dublin, IE)
Slides Video

Access the full session

Session thumbnail
Challenges with antithrombotic strategies in atrial fibrillation and coronary disease: time to personalise?
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:00 CET
You may be interested in
thumbnail
Congress Session
Left atrial appendage occlusion news: hot off the press
27 August 2022
thumbnail
Congress Presentation
Is left atrial appendage closure replacing oral anticoagulation?: pro
30 August 2026
thumbnail
Congress Presentation
Reduced-dose direct oral anticoagulation vs antiplatelet strategies after left atrial appendage occlusion in atrial fibrillation. a triple target trial emulation from a federated research network
29 August 2026
thumbnail
Congress Presentation
Left atrial appendage occlusion should always be considered: con
20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources